455 reports of this reaction
3.3% of all GUANFACINE reports
#3 most reported adverse reaction
SOMNOLENCE is the #3 most commonly reported adverse reaction for GUANFACINE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 455 FDA adverse event reports linking GUANFACINE to SOMNOLENCE. This represents approximately 3.3% of all 13,968 adverse event reports for this drug.
Patients taking GUANFACINE who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SOMNOLENCE is moderately reported among GUANFACINE users, representing a notable but not dominant share of adverse events.
In addition to somnolence, the following adverse reactions have been reported for GUANFACINE:
The following drugs have also been linked to somnolence in FDA adverse event reports:
SOMNOLENCE has been reported as an adverse event in 455 FDA reports for GUANFACINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SOMNOLENCE accounts for approximately 3.3% of all adverse event reports for GUANFACINE, making it one of the most commonly reported side effect.
If you experience somnolence while taking GUANFACINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.